0.6502

2.91% -0.0195

After Hours: .65 -0.0002 -0.03%

Werewolf Therapeutics Inc (HOWL)

Overview News Price History Option Chain Financials Discussions Forecast

Werewolf Therapeutics Inc stock is traded at $0.6502, with a volume of 298.97K. It is down -2.91% in the last 24 hours and down -37.48% over the past month. Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.

Previous Close:

$0.6697

Open:

$0.7054

24h Volume:

298.97K

Relative Volume:

0.82

Market Cap:

$31.60M

Revenue:

$1.14M

Net Income/Loss:

$-60.82M

P/E Ratio:

-0.4875

EPS:

-1.3338

Net Cash Flow:

$-60.29M

1W Performance:

-4.38%

1M Performance:

-37.48%

6M Performance:

-45.82%

1Y Performance:

-30.09%

1-Day Range:

$0.65

$0.7167

1-Week Range:

$0.65

$0.75

52-Week Range:

$0.5301

$2.38

Werewolf Therapeutics Inc Stock (HOWL) Company Profile

Name

Werewolf Therapeutics Inc

Sector

Healthcare (1111)

Industry

Biotechnology (621)

Phone

617-952-0555

Address

200 TALCOTT AVENUE, WATERTOWN

Employee

Twitter

Next Earnings Date

2026-05-14

Latest SEC Filings

HOWL's Discussions on Twitter

Compare HOWL vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HOWL Werewolf Therapeutics Inc	0.6502	32.55M	1.14M	-60.82M	-60.29M	-1.3338
VRTX Vertex Pharmaceuticals Inc	427.65	107.87B	12.32B	4.34B	3.19B	16.86
REGN Regeneron Pharmaceuticals Inc	721.05	73.63B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	807.55	49.42B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	303.00	40.20B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	313.32	33.06B	5.36B	287.73M	924.18M	2.5229

Werewolf Therapeutics Inc Stock (HOWL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-19-25	Downgrade	Wedbush	Outperform → Neutral
Apr-03-24	Initiated	JMP Securities	Mkt Outperform
Aug-24-23	Initiated	Wedbush	Outperform
Jun-06-23	Resumed	Jefferies	Buy
Sep-10-21	Initiated	BofA Securities	Buy
May-25-21	Initiated	Evercore ISI	Outperform
May-25-21	Initiated	H.C. Wainwright	Buy
May-25-21	Initiated	Jefferies	Buy
May-25-21	Initiated	SVB Leerink	Outperform

View All

Werewolf Therapeutics Inc Stock (HOWL) Latest News

May 05, 2026

Werewolf Therapeutics (ticker: HOWL) holders detail stake and sales in 13D/A - Stock Titan

May 05, 2026

How Werewolf Therapeutics (HOWL) earnings power compares to its price (Mini Selloff) 2026-05-05Fundamentals - Newser

May 05, 2026

May 04, 2026

Werewolf Therapeutics director Luke Evnin sells $198,309 in shares - Investing.com

May 04, 2026

Werewolf Therapeutics (NASDAQ: HOWL) entities sell 274K shares - Stock Titan

May 04, 2026

May 01, 2026

Werewolf Therapeutics (HOWL) price target increased by 12.00% to 7.14 - MSN

May 01, 2026

Apr 29, 2026

Werewolf Therapeutics director Luke Evnin sells $154,525 in stock - Investing.com

Apr 29, 2026

Werewolf Therapeutics (HOWL) stake trimmed by MPM entities in planned sales - Stock Titan

Apr 29, 2026

[144] Werewolf Therapeutics, Inc. SEC Filing - Stock Titan

Apr 29, 2026

MSN Money - MSN

Apr 29, 2026

Werewolf Therapeutics Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView

Apr 29, 2026

Apr 24, 2026

HOWL Price Today: Werewolf Therapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange

Apr 24, 2026

Apr 20, 2026

Werewolf Therapeutics (HOWL) Stock Bid Wall (Smart Money Exits) 2026-04-20Swing Signals - Newser

Apr 20, 2026

Apr 16, 2026

HOWL Forecast, Price Target & Analyst Ratings | WEREWOLF THERAPEUTICS INC (NASDAQ:HOWL) - ChartMill

Apr 16, 2026

Apr 13, 2026

Geopolitics Watch: Does Werewolf Therapeutics Inc have consistent dividend growthExit Point & Free Long-Term Investment Growth Plans - baoquankhu1.vn

Apr 13, 2026

Apr 07, 2026

Werewolf Therapeutics (NASDAQ:HOWL) Raised to “Hold” at Wall Street Zen - Defense World

Apr 07, 2026

Apr 03, 2026

HOWL Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 03, 2026

HOWL Should I Buy - Intellectia AI

Apr 03, 2026

Apr 01, 2026

Investment Report: Is now the right time to enter Werewolf Therapeutics IncWeekly Trend Recap & Capital Efficient Trading Techniques - baoquankhu1.vn

Apr 01, 2026

Werewolf Therapeutics Faces Nasdaq Delisting Risk After Falling Below $1 Minimum Bid Price - TipRanks

Apr 01, 2026

Mar 31, 2026

HOWL PE Ratio & Valuation, Is HOWL Overvalued - Intellectia AI

Mar 31, 2026

Aug Action: Is now the right time to enter Werewolf Therapeutics Inc2026 Technical Patterns & Accurate Buy Signal Alerts - baoquankhu1.vn

Mar 31, 2026

Mar 29, 2026

Werewolf Therapeutics (HOWL) price target increased by 20.19% to 6.38 - MSN

Mar 29, 2026

Mar 27, 2026

Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates - bitget.com

Mar 27, 2026

Werewolf Therapeutics reports Q4 EPS (20c), consensus (35c) - tipranks.com

Mar 27, 2026

Werewolf Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener

Mar 27, 2026